Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley R Riddell

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Cell|August 5, 2022
Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancerJoshua R Veatch, Stanley R Riddell
Cancer Cell|April 12, 2022
Synthetic HLA-independent T cell receptors for cancer immunotherapySylvain Simon, Grace Bugos, Stanley R Riddell
The Journal of Experimental Medicine|May 14, 2003
A human minor histocompatibility antigen resulting from differential expression due to a gene deletionMakoto Murata, Edus H Warren, Stanley R Riddell
Expert Review of Hematology|September 21, 2012
Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantationMarie Bleakley, Cameron J Turtle, Stanley R Riddell
Science Translational Medicine|March 27, 2015
Adoptive cellular therapy: a race to the finish lineCarl H June, Stanley R Riddell, Ton N Schumacher
Blood|May 6, 2018
Chimeric antigen receptor-modified T cells: CD19 and the road beyondAlexander I Salter, Margot J Pont, Stanley R Riddell
Expert Opinion on Biological Therapy|August 21, 2007
Genetic modification of T cells for immunotherapyCarolina Berger, Michael Berger, Junli Feng, et al.
Chimerism|February 18, 2011
Double unit cord blood transplantation: Who wins-and why do we care?Jonathan A Gutman, Stanley R Riddell, Suzanne McGoldrick, et al.
International Journal of Hematology|November 15, 2002
Minor histocompatibility antigens--targets of graft versus leukemia responsesStanley R Riddell, M Murata, S Bryant, et al.
Current Opinion in Immunology|September 27, 2021
Synthetic receptors for logic gated T cell recognition and functionSylvain Simon, Grace Bugos, Alex I Salter, et al.
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Cell|August 5, 2022
Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancerJoshua R Veatch, Stanley R Riddell
Cancer Cell|April 12, 2022
Synthetic HLA-independent T cell receptors for cancer immunotherapySylvain Simon, Grace Bugos, Stanley R Riddell
The Journal of Experimental Medicine|May 14, 2003
A human minor histocompatibility antigen resulting from differential expression due to a gene deletionMakoto Murata, Edus H Warren, Stanley R Riddell
Expert Review of Hematology|September 21, 2012
Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantationMarie Bleakley, Cameron J Turtle, Stanley R Riddell
Science Translational Medicine|March 27, 2015
Adoptive cellular therapy: a race to the finish lineCarl H June, Stanley R Riddell, Ton N Schumacher
Blood|May 6, 2018
Chimeric antigen receptor-modified T cells: CD19 and the road beyondAlexander I Salter, Margot J Pont, Stanley R Riddell
Expert Opinion on Biological Therapy|August 21, 2007
Genetic modification of T cells for immunotherapyCarolina Berger, Michael Berger, Junli Feng, et al.
Chimerism|February 18, 2011
Double unit cord blood transplantation: Who wins-and why do we care?Jonathan A Gutman, Stanley R Riddell, Suzanne McGoldrick, et al.
International Journal of Hematology|November 15, 2002
Minor histocompatibility antigens--targets of graft versus leukemia responsesStanley R Riddell, M Murata, S Bryant, et al.
Current Opinion in Immunology|September 27, 2021
Synthetic receptors for logic gated T cell recognition and functionSylvain Simon, Grace Bugos, Alex I Salter, et al.
Pageof 18